Indication
Vulvar Lichen Sclerosus
5 clinical trials
5 products
Clinical trial
A Parallel Group (2-arm), Randomised, Double-blind, 12-week Trial to Explore the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in Women Diagnosed With Vulvar Lichen Sclerosus (VLS)Status: Recruiting, Estimated PCD: 2024-05-27
Product
MC2-25Clinical trial
A Randomized, Unblinded Trial of Topical Steroids Plus CO2 Laser Compared to Steroids Alone in the Treatment of Vulvovaginal Lichen SclerosusStatus: Recruiting, Estimated PCD: 2025-04-13
Product
Topical steroidClinical trial
Prospective, Randomized, Active-controlled Investigator Initiated Clinical Trial to Demonstrate That the Nd:YAG/Er:YAG Dual Laser Therapy is Effective to Treat Vulvar Lichen Sclerosus and Similar to Standard Treatment With Steroid CreamStatus: Active (not recruiting), Estimated PCD: 2024-05-30
Product
Clobetasol propionateClinical trial
A Pilot, Randomized, Blinded, Controlled Study Evaluating Autologous Platelet-Rich Plasma for the Treatment of Vulvar Lichen SclerosusStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Randomized Controlled Trial of Vulvar Fractionated CO2-Laser Therapy With and Without Concomitant Topical Clobetasol Propionate 0.05% Ointment for Treatment of Vulvar Lichen SclerosusStatus: Recruiting, Estimated PCD: 2024-07-30
Product
Clobetasol Propionate